United Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,280	1,557	1,697	1,208	961.2	894.8
Short-Term Investments	874	1,363	1,570	1,786	1,878	1,036
Cash & Short-Term Investments	2,154	2,920	3,267	2,994	2,839	1,931
Cash Growth	-35.15%	-10.61%	9.12%	5.47%	47.03%	5.21%
Accounts Receivable	312	350.2	279.3	278.9	220.4	198.7
Inventory	178.3	183.1	157.9	111.8	102	93.8
Other Current Assets	228	248.9	169.7	166.2	219.2	100.4
Total Current Assets	2,872	3,703	3,874	3,551	3,380	2,324
Net Property, Plant & Equipment	1,841	1,730	1,222	1,045	861.5	780.9
Goodwill	115.5	116.5	111.9	114.2	44.5	44.6
Long-Term Investments	1,317	1,777	1,475	1,910	1,316	1,650
Other Long-Term Assets	568.6	554.6	680.5	546.6	442	370.1
Total Assets	6,714	7,880	7,364	7,167	6,045	5,169
Accounts Payable	498.3	488	344.5	298	229.9	174.6
Short-Term Debt	-	-	300	400	-	-
Other Current Liabilities	100.8	72.6	93.6	106.4	113.3	130.8
Total Current Liabilities	599.1	560.6	738.1	804.4	343.2	305.4
Long-Term Debt	-	-	-	300	800	800
Other Long-Term Liabilities	214	223.2	181.9	77.8	104.6	104.8
Total Long-Term Liabilities	214	223.2	181.9	377.8	904.6	904.8
Total Liabilities	813.1	783.8	920	1,182	1,248	1,210
Common Stock	0.8	0.8	0.8	0.7	0.7	0.7
Treasury Stock	-5,442	-4,260	-3,475	-2,579	-2,579	-2,579
Additional Paid-in Capital	2,520	2,798	2,699	2,549	2,388	2,245
Accumulated Other Comprehensive Income	-10.2	0.9	-3.4	-12.8	-55.5	-23
Retained Earnings	8,832	8,557	7,222	6,027	5,042	4,315
Shareholders' Equity	5,901	7,096	6,444	5,985	4,797	3,959
Total Liabilities & Equity	6,714	7,880	7,364	7,167	6,045	5,169
Total Debt	-	0	300	700	800	800
Net Cash (Debt)	2,154	2,920	2,967	2,294	2,039	1,131
Net Cash Growth	-26.25%	-1.57%	29.33%	12.53%	80.30%	9.25%
Net Cash Per Share	45.32	60.97	61.17	46.16	42.03	23.91
Book Value	5,901	7,096	6,444	5,985	4,797	3,959
Book Value Per Share	124.17	148.15	132.87	120.42	98.90	83.70
Tangible Book Value	5,786	6,980	6,332	5,871	4,752	3,914
Tangible Book Value Per Share	121.74	145.71	130.56	118.12	97.98	82.75

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q